Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Clarifies ‘Intended Use’ Policy For Approved Products

Jan 17 2017

• By Brenda Sandburg

FDAEntrance_1200x675

Related Content

FDA Off-Label Reg Changes For Drugs Could Be Driven By Tobacco Policy

Oct 07 2015

Off-Label Communications: Industry, FDA Debate Role Of Peer Review

Nov 10 2016

Related Companies

Pfizer Inc.

Additional Topics

FDA BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window